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ABSTRACT 
Introduction: Pancreatic ductal adenocarcinoma (PDAC) is a devastating diagnosis for anyone as it is 
associated with a global mortality rate of about 4%, and has few therapeutic interventions that prolong 
survival as compared to other cancers. Frequent epidemiological reports on PDAC are available in the 
developed countries, but in South Africa, there is a paucity of epidemiological data on this aggressive 
cancer. Understanding risk factors will help to assess and develop relevant interventions for 
asymptomatic high-risk patient populations.  
 
Aim: To investigate and explore how various risk factors were associated with PDAC at two public 
academic hospitals in Johannesburg between 2013 and 2015. 
 
Method: This was a secondary unmatched case-control study to assess risk factors for developing 
PDAC at two public academic hospitals, namely the Chris Hani Baragwanath Academic Hospital 
(CHBAH) and the Charlotte Maxeke Johannesburg Academic Hospital (CMJAH). All cases of PDAC 
were histologically and/or cytologically confirmed. All participants were >18 years of age, including 
139 cases and 139 controls. Data exported from REDCap database included patient demographics and 
social and medical histories. Proportions used the chi-square test and bivariate logistic regression 
estimated ORs between individual variables and PDAC. Multivariate logistic regression analysis 
investigated all possible confounders present in the data. The likelihood ratio test with a p-value of 
<0.20 was accepted to assimilate data fitting into the model. 
 
Results: Eighty two percent of the study population was black. The 50-59 age group accounted for 37% 
of the cases. Multiple logistic regressions showed the following odds ratios 95% CI and p-values for 
ages (i) 20-29 [0.11(0.11-1.00) p=0.05] and (ii) 50-59 [2.63(1.03-6.70) p=0.04]. As for diet, the 
following odds were observed (i) high white meat [0.18(0.04-0.86) p=0.03], (ii) low fish intake 
[2.17(1.06-4.45) p=0.03], (iii) low consumption of fried food [0.48(0.23-1.00) p=0.05] and (iv) high 
consumption of vegetables [0.17(0.05-0.61) p=0.007]. In terms of occupation, general workers had the 
following likelihood [1.79(0.93-3.45) p=0.08] of developing PDAC. 
 
Conclusion: Being 50-69 years of age and employed for longer periods than the general norm, was 
positively associated with PDAC. Additionally, increased consumption of vegetables and white meat 
was protective against PDAC, whilst a low intake of fish increased PDAC risk. 
 
Keywords: Pancreatic cancer, risk factors, epidemiology and case-control.  
 
0405483M 
 
ii | P a g e  
 
TABLE OF CONTENTS 
  
1. Introduction ........................................................................................................................ 1 
1.1 Background Information ............................................................................................. 1 
1.2 Problem Statement ...................................................................................................... 1 
1.3 Justification ................................................................................................................. 2 
1.4 Literature Review ........................................................................................................ 2 
1.4.1 Incidence of PDAC .............................................................................................. 2 
1.4.2 Risks Factors of PDAC ........................................................................................ 3 
1.4.2.3 Lifestyle ............................................................................................................ 4 
1.5 Research Question ....................................................................................................... 6 
1.6 Aim .............................................................................................................................. 6 
1.7 Objectives .................................................................................................................... 6 
2 Methods................................................................................................................................... 8 
2.1 Primary study .............................................................................................................. 8 
2.2 Study site ..................................................................................................................... 8 
2.3 Study population ......................................................................................................... 8 
2.4 Sample size and power ................................................................................................ 9 
2.5 Data collection............................................................................................................. 9 
2.6 Data management and analysis ................................................................................. 17 
2.6.1 Data management .................................................................................................... 17 
2.6.2 Statistical analysis .............................................................................................. 17 
2.7 Ethical considerations ............................................................................................... 18 
2.8 Study Budget .................................................................................................................. 18 
3. Results .................................................................................................................................. 19 
3.1 Introduction ............................................................................................................... 19 
3.1.1 Demographic characteristics of study population .............................................. 23 
0405483M 
 
iii | P a g e  
 
3.1.2 Social characteristics of study population.......................................................... 23 
3.1.3 Chronic Medical characteristics of study population......................................... 23 
3.1.4 Dietary characteristics of study population ........................................................ 24 
3.1.5 Hospital characteristics for the study population ............................................... 24 
3.2.1 Adjusted and unadjusted demographic factors associated with PDAC ................... 24 
3.2.3 Adjusted and unadjusted dietary factors associated with PDAC ............................ 24 
3.2.3 Adjusted and unadjusted social factors associated with PDAC .............................. 24 
3.2.5 Final model .............................................................................................................. 25 
4. Discussion ............................................................................................................................ 28 
4.1 Introduction .................................................................................................................... 28 
4.2 Risk factors for patients with PDAC .............................................................................. 31 
4.2.1 Age and Gender ....................................................................................................... 31 
4.2.2 Alcohol .................................................................................................................... 31 
4.2.3 Diet ..................................................................................................................... 32 
4.2.4 Employment............................................................................................................. 32 
4.3 Study limitations ............................................................................................................ 33 
5. Conclusions and recommendations...................................................................................... 34 
5.1 Introduction ............................................................................................................... 34 
5.2 Conclusions ............................................................................................................... 34 
5.3 Recommendations ..................................................................................................... 34 
5.4 Future studies ............................................................................................................ 35 
6 References ............................................................................................................................. 36 
7. Appendix .............................................................................................................................. 41 
 
0405483M 
 
iv | P a g e  
 
List of abbreviations 
AIDS - Acquired Immune Deficiency Syndrome  
AOR - Adjusted Odd Ratio 
BMI - Basal metabolic index 
CAGE - Cut Annoyed Guilty Eye-opener 
CHBAH - Chris Hani Baragwanath Academic Hospital 
CMJAH - Charlotte Maxeke Johannesburg Academic Hospital 
COPD - Chronic Obstructive Pulmonary Disease 
CP - Chronic Pancreatitis 
CT scan - Computerized (or computed) tomography scans 
DM - Diabetes mellitus 
H Pylori - Helicobacter pylori 
HIV- Human Immune Deficiency Virus 
IBD - Inflammatory bowel disease 
GIT - Gastro-intestinal-tract  
LC-PUFA - Long-Chain Polyunsaturated Fatty Acids  
NCD - Non-Communicable Disease 
NRF - National Research Foundation 
OR - Odds Ratio 
PDAC - Pancreatic Ductal Adenocarcinoma 
REDCap- Research Electronic Data Capture 
SD - Standard Deviation 
SEER - Surveillance, Epidemiology, and End Results 
0405483M 
 
v | P a g e  
 
Stata - Statistical analysis programme 
TB - Tuberculosis 
UOR - Unadjusted Odds Ratio 
WHO - World Health Organization 
  
0405483M 
 
vi | P a g e  
 
List of figures 
Figure 1. Flow chart of proceedure embarked on for data collection............................... 10 
Figure 2 Letter from the gatekeeper .................................................................................... 41 
Figure 3 Letter to the gatekeeper ......................................................................................... 42 
Figure 4 Ethic clearance ........................................................................................................ 44 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0405483M 
 
vii | P a g e  
 
List of tables 
Table 1. Exposure variables and measurements ................................................................. 11 
Table 2. Objectives of the study and corresponding analysis undertaken ....................... 17 
Table 3 Baseline characteristics ............................................................................................ 20 
Table 4 Diet ............................................................................................................................. 21 
Table 5 Social characteristics ................................................................................................ 22 
Table 6 Unadjusted and Adjusted OR for PDAC ............................................................... 26 
Table 7 Demographic characteristics of study population ................................................. 45 
Table 8Social characteristics of study population .............................................................. 47 
Table 9 Chronic Medical characteristics of the study population ..................................... 49 
Table 10Dietary characteristics of study population .......................................................... 51 
Table 11Hospital characteristics for the study population ................................................ 53 
Table 12Factors associated with PDAC ............................................................................... 54 
Table 13Chronic medical factors associated with PDAC ................................................... 56 
Table 14Dietary factors associated with PDAC .................................................................. 58 
Table 15Social factors associated with PDAC ..................................................................... 60 
Table 16Hospital factors associated with PDAC................................................................. 62 
Table 17Final model .............................................................................................................. 63 
0405483M 
 
1 | P a g e  
 
1. Introduction 
This chapter discusses the background information regarding pancreatic ductal 
adenocarcinoma (PDAC), explains the results reported in the literature, describe the problem 
statement of the study and the justification for this research. The chapter ends with the 
research question statement and a description of the aim and objectives of the study. 
1.1 Background Information 
Cancer is one of the most important health problems worldwide due to its high mortality rate 
(Ferlay, Soerjomataram et al. 2012), primarily as a result of its ability to spread from a 
primary site to distant organs through a process known as metastasis (Khan and Mukhtar, 
2010). Pancreatic cancer commonly known as  pancreatic ductal adenocarcinoma (PDAC) 
is globally ranked thirteenth among all cancers in terms of incidence, but ranked seventh in 
terms of mortality (Kuzmickiene, Everatt et al. 2013). PDAC is the most common epithelial 
pancreatic malignancy (Hariharan, Saied et al. 2008) and accounts for the highest percentage 
(greater than 80%) of all malignant pancreatic tumours (Alexakis, Halloran et al. 2004). In 
both genders PDAC has an almost equal number of incidences and annual mortality rate 
(Are, Chowdhury et al. 2016). There is limited data on PDAC in Africa probably due to lack 
of infrastructure and resource constraints as evidenced by poorly developed primary 
healthcare systems with its resulting negative impact on referral patterns, as well  as the 
scarcity of well-developed tertiary care and multidisciplinary centres (Shrikhande, Barreto 
et al. 2012).  Furthermore, there is no effective screening test for PDAC and therefore, it is 
often diagnosed at an advanced stage, contributing to a 5 year survival rate of less than 5% 
(Fest, Ruiter et al. 2017). 
The anatomical location of the occurrence of PDAC contributes to the reason for late 
presentation of patients. The early stages are asymptomatic thereby making diagnosis 
difficult (Miroslaw, Sekula et al. 2012), thus in most patients a high index of clinical 
suspicion  is required with the non-specific symptoms of painless obstructive jaundice, 
weight loss and back pain (Alexakis, Halloran et al. 2004).  Other associated signs and 
symptoms such as late-onset diabetes mellitus may suggest PDAC as well as persistent non-
orthopaedic associated back pain, marked rapid weight loss, an epigastric abdominal mass, 
ascites and supraclavicular lymphadenopathy may all indicate a potentially advanced  
tumour (Alexakis, Halloran et al. 2004).  
1.2 Problem Statement 
PDAC is a devastating diagnosis for any patient, as it is associated with a mortality rate of 4 
per 100 000 population and few therapeutic interventions that prolong survival compared to 
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other cancers. The epidemiological data for PDAC have mostly been reported in developed 
countries. In South Africa however, there is paucity of epidemiological data on this 
aggressive cancer (Soliman , Zhang et al. 2006).  The most recent National Cancer Registry 
reports a PDAC incidence for the year 2012 and there has been no update since then (Herbst 
and Joubert 2017). This may give the misconception that the incidence of PDAC is rare in 
South Africa. In the past decade the epidemics of HIV and TB re-directed resources from 
NCDs, which resulted in low-cost passive surveillance activities with a 10 year backlog of 
incidence reports (Singh, Ruff et al. 2015). Besides the backlog the pathology-based data 
may be clinically underestimated as this data is not linked to mortality data (Singh, Ruff et 
al. 2015). The other challenges of cancer registries in Africa include: financial constraints 
for implementation of registries according to the WHO guidelines and lack of trained 
personnel for long-term sustainability (Singh, Ruff et al. 2015). Since PDAC is not one of 
the top five causes of death attributed to cancer, not much resource allocation is given. 
Updated epidemiological data concerning this disease in South Africa will improve the 
understanding of it and instigate primary health care initiatives that may address issues 
unique to South Africa. 
1.3  Justification 
Understanding risk factors associated with the disease will help to assess and develop 
relevant interventions, as well as allocate primary health care resources for patients at risk. 
A well-managed research programme, mitigation of the disease impacts and implementation 
of a contingency plan especially for the less privileged communities in South Africa, would 
be of value. Diagnosis of PDAC at an advanced stage and knowing the potential factors 
associated with it will provide information for better screening and management of potential 
future patients. Early diagnosis may increase the survival of PDAC patients and this study 
may increase awareness of the disease in the South African population. This study provides 
an opportunity for the monitoring of risk for developing PDAC within the population and 
age groups at risk.  
1.4 Literature Review  
In this section, a review of the incidence rate and risk factors for PDAC will address a gap 
in the knowledge of the disease in the specific context of South Africa.  
1.4.1 Incidence of PDAC 
PDAC is a lethal malignancy that accounts for approximately 4% of cancer deaths 
worldwide (Ferlay, Soerjomataram et al. 2012, Are, Chowdhury et al. 2016). In the United 
States of America (US), the incidence rate is 2.7% of all new cancer diagnosis.  The global 
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incidence rate of PDAC for all age groups of both sexes is 4.2 per 100 000 with a mortality 
rate of 4.0 per 100 000 population. The six different WHO regions (Africa, America, Eastern 
Mediterranean, Europe, South East Asia and Western Pacific) have varying incidence rates. 
The incidence rates for all age groups of both sexes are as follows: Africa 1.8 per 100 000 
population, America 5.9 per 100 000 population, Eastern Mediterranean 1.9 per 100 000 
population, Europe 6.5 per 100 000 population, South East Asia 1.5 per 100 000 population 
and Western Pacific 4.4 per 100 000 population (Ferlay, Soerjomataram et al. 2012, Are, 
Chowdhury et al. 2016). The incidence rate of PDAC in relation to socio-economic 
development for all age groups of both sexes varies from 1.2 per 100 000 population in the 
low socio-economic development category to as high as 7.2 per 100 000 population in the 
very high socio-economic development category (Ferlay, Soerjomataram et al. 2012, Are, 
Chowdhury et al. 2016).   In 2012 PDAC accounted for 0.52% in all males and 0.39%% in 
all females as a percentage of all cancers in South Africa (Herbst and Joubert 2017). In 2014, 
the WHO reported the death rate of PDAC as 4.34 per 100 000 population for South Africa 
and South Africa was thus ranked 67th  for PDAC incidence in the world (Le Duc 2017). The 
PDAC incidence rate for South Africa in 2012 for all age groups of both sexes, according to 
Globocan, was  4.7 per 100 000 population with a mortality rate of 4.6 per 100 000 
population (Ferlay, Soerjomataram et al. 2012). 
1.4.2 Risks Factors of PDAC 
PDAC is caused by both genetic coding (such as inherited mutations) and 
environmental/acquired factors (such as tobacco, diet, radiation, and infectious organisms) 
(Anand, Kunnumakara et al. 2008, Kuzmickiene, Everatt et al. 2013). Established risk 
factors for PDAC include smoking (Iodice, Gandini et al. 2008, Lynch, Vrieling et al. 2009, 
Bosetti, Lucenteforte et al. 2012), alcohol consumption (Michaud, Vrieling et al. 2010, 
Lucenteforte, La Vecchia et al. 2012), diabetes mellitus (Chari, Leibson et al. 2005, Huxley, 
Ansary-Moghaddam et al. 2005, Chari, Leibson et al. 2008), obesity (Tang, Wei et al. 2014) 
and  diseases associated with chronic inflammation (Michaud, Vrieling et al. 2010). Chronic 
inflammation is a recognised factor in the initiation of carcinogenesis (Sobhani, Amiot et al. 
2013) and as such is evident in the development of various diseases such as: inflammatory 
bowel disease (IBD), colon cancer,  Helicobacter pylori induced gastritis, gastric cancer 
(Correa, Haenszel et al. 1990), chronic pancreatitis and PDAC (Duell, Lucenteforte et al. 
2012). Other risk factors include age, occupation, gender and race (Muniraj, Jamidar et al. 
2013). 
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1.4.2.1  Age 
The risk of PDAC increases with age, with most cases from 45 years upwards (Ries, 
Reichman et al. 2003). Indeed, advancing age is the main risk factor for developing PDAC, 
a factor not uncommon to most cancers (Yeo and Lowenfels 2012). Data from the 
Surveillance, Epidemiology, and End Results (SEER) registries show the median age of 
PDAC diagnosis to be 71 years, where less than 3% of cases were diagnosed before age 44 
and 54% of cases between 65 and 84 years of age (Yeo and Lowenfels 2012). The less than 
0.5% of cases in the age range of 20 years and below, may be attributed  to family history or 
to genetic factors in those at risk of developing PDAC (Yeo and Lowenfels 2012). 
1.4.2.2 Gender and Race 
The incidence rate of PDAC is higher in men than in women. This difference may be due to 
higher tobacco use in men than in women (Yeo and Lowenfels 2012). In addition, men tend 
to consume more fried, grilled, or barbecued meat than women and this increase the risk of 
PDAC (Pericleous, Rossi et al. 2014).  In the US, the incidence of PDAC is higher in African 
Americans compared with Caucasians. The differences in incidences reported in gender and 
in race may be due to higher rates of the associated risk factors such as diabetes and obesity 
in women, and smoking in men (Yeo and Lowenfels 2012).  
1.4.2.3  Lifestyle – smoking, alcohol, weight and diet 
Smoking is the strongest risk factor for PDAC (Duell, Lucenteforte et al. 2012). It is believed 
to cause 30% of all cases (Konner and O’Reilly 2002). A meta-analysis by Iodice et al., 
(2008) indicated that current cigarette smokers, compared with non-smokers, have 
approximately an 1.7 risk ratio of PDAC and this increases as the number of cigarettes 
smoked and the number of years of smoking increases (Iodice, Gandini et al. 2008). Tobacco 
smoking has the greatest risk. The other risk linked to tobacco include smokeless tobacco 
(chewing tobacco) and environmental tobacco smoke, although it appears discordant or 
negative (Maisonneuve and Lowenfels 2015). 
 
Heavy and moderate alcohol consumption has been found to have an effect on the risk of 
PDAC development through the activation of inflammatory pathways in chronic pancreatitis 
(CP) (Duell, Lucenteforte et al. 2012).  Although CP has a low prevalence, alcohol 
consumption leads to progressive and irreversible tissue destruction following inflammation 
(Michaud, Vrieling et al. 2010, Lucenteforte, La Vecchia et al. 2012). The incidence of 
alcohol induced CP resulting in PDAC is  3-5% of all PDAC cases (Konner and O’Reilly 
2002). A heavy drinking pattern (>80g  alcohol/day, or more than 5–6 drinks/day.) 
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comprising of wine, beer and other liquor increases the risk  for developing PDAC (Ruiz 
and Hernández 2014)   
Being overweight or obese increases the risk of PDAC development due to an increased 
production of hormones, inflammatory markers and growth factors (Li, Xie et al. 2004, Ruiz 
and Hernández 2014).  Increases in circulating insulin and C-peptide, hyperglycaemia, 
insulin resistance and diabetes account for a possible development of PDAC. Extra weight 
around the waistline especially in women, may also be a risk factor of PDAC (Li, Xie et al. 
2004). Generally, there is an increasing risk of  PDAC with decreasing physical inactivity 
(Behrens, Jochem et al. 2015).  
It has been suggested that diet plays a crucial role in predisposing an individual to PDAC 
(Al-Majeda, El-Basmib et al. 2013). However, there is conflicting evidence for the effect of 
diet on PDAC risk (Neale, Clarka et al. 2014). In a review, high red meat (beef, lamb, goat, 
venison, etc.) consumption increased the risk of developing PDAC, particularly in men. On 
the other hand, multiple studies have observed that consuming foods of high vegetable, fruit 
and whole grain content confer protection against PDAC (Neale, Clarka et al. 2014). A 
healthy eating pattern which includes a high content of fruits, vegetables, poultry, fish, whole 
grain and low daily intake of fat has a protective effect from PDAC development (Ruiz and  
Hernández 2014). Processed and smoked foods such as ham, sausages, bacon, burgers, foods 
high in fat and refined sugars increase the risk of developing PDAC (Jansen, Robinson et al. 
2014, Ruiz and Hernández 2014). 
1.4.2.4 Some medical conditions  
1.4.2.4.1 Chronic pancreatitis (CP) 
Chronic pancreatitis (CP) increases the risk of PDAC. Indeed, a review article shows the 
progression of CP over a period of 20 years until diagnosis of PDAC   (Pinho, Chantrill et 
al. 2014). The K-ras mutation  observed in CP is implicated in the  activation and the 
progression to PDAC (Yeo and Lowenfels 2012). Furthermore, the digestive enzyme-
secreting acinar cells undergo ductal metaplasia in the inflammatory environment of 
pancreatitis, and this metaplastic change is recognized as a precursor of PDAC (Pinho,  
Chantrill et al. 2014).  
1.4.2.4.2 Diabetes Mellitus (DM) 
Strong evidence exists that DM is associated with PDAC. Type 2 DM is probably second 
(just after cigarette smoking) on the list of the top five modifiable risk factors for PDAC. 
Epidemiological investigations found that long-term Type 2 DM is associated with a 1.5-
fold to 2.0-fold increase in the risk for developing PDAC (Li 2012). Long-term diabetes was 
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observed to account for more than 50% of all PDAC sufferers (Maisonneuve and Lowenfels 
2015). 
1.4.2.5 Infections  
1.4.2.5.1 Hepatitis B 
There is strong evidence that hepatitis B is associated with PDAC, since hepatitis B positive 
carriers showed a relative risk of between 1.2-3.8 for developing PDAC (Maisonneuve and 
Lowenfels 2015). The virus tends to infect the pancreas and liver of chronic hepatitis B 
carriers (Yeo and Lowenfels 2012). However, both hepatitis B and hepatitis C may be 
involved in a process of oncogenesis through development of local inflammation in the 
pancreas. The pancreas serves as a reservoir for the replication of the virus which in turn 
causes necro-inflammation in the pancreas (Fiorino, Cuppini et al. 2013).  
1.4.2.5.2 Helicobacter pylori (H pylori) and blood group 
Helicobacter pylori infection increases the risk of PDAC development (Fiorino, Cuppini et 
al. 2013). Helicobacter pylori and peptic ulcers activate N-nitrosamines which may cause 
DNA damage resulting in progression to PDAC (Yeo and Lowenfels 2012). Interestingly, 
in the presence of duodenal ulcers and H Pylori, all blood groups except the O blood group,  
show a risk of developing PDAC (Yeo and Lowenfels 2012). Indeed, blood group A 
individuals has the worst survival rates of all PDAC sufferers (Kos, Civelek et al. 2012). 
1.4.2.6 Occupational exposures 
Exposure to chlorinated hydrocarbons and related solvent compounds are among the major 
occupational risk factors for development of PDAC. Additionally, nickel plating and 
formaldehyde exposure cause moderate risk of PDAC (Maisonneuve and Lowenfels 2015). 
Furthermore, Yeo et al. (2012) observed that exposure to asbestos, pesticides, herbicides, 
residential radon, coal products, welding products and radiation are all associated with 
PDAC (Yeo and Lowenfels 2012). 
1.5 Research Question   
What are the risk factors associated with PDAC in patients admitted at two public academic 
hospitals in Johannesburg between June 2013 and December 2015? 
1.6 Aim 
The aim of this study was to investigate and explore how various risk factors were associated 
with PDAC at two public academic hospitals in Johannesburg between 2013 and 2015. 
1.7 Objectives 
1. To describe demographic, social, hospital and dietary characteristics of patients with 
PDAC in two public academic hospitals in Johannesburg. 
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2. To assess the risk factors associated with patients diagnosed with PDAC in two 
public academic hospitals in Johannesburg. 
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2 Methods 
This chapter describes the methods used to collect and manage data, perform statistical 
analysis and the ethical considerations. First, the chapter describes the study design, the 
setting, and how the sample size was calculated. It further explains the study population.  
The study used an unmatched case-control design to assess detailed information on risk 
factors for PDAC between June 2013 and December 2015. Data used was from a primary 
study, which was a hospital based, case-control study that is on-going. Participant’s 
demographics, social and medical history from study questionnaires captured in the REDCap 
(Research Electronic Data Capture) programme (Harrisa, Taylorb et al. 2009) was imported 
into Stata 13 and Excel. For this study, data was analysed as explained by Figure 1. 
2.1 Primary study 
The primary study focused on the genetic and environmental factors that influence 
susceptibility to PDAC. This included evaluation of the possible associations between the 
inter-individual genetic variation and the risk of developing PDAC, disease progression and 
the survival of the patients as well as their response to the treatment. More specifically the 
study objectives were: 
 To identify new genetic risk factors for PDAC, in addition to those identified to date. 
 To describe genetic factors which influence the outcome of treatment of PDAC patients. 
 To assess the genetic factors which influence the survival of PDAC patients. 
2.2 Study site 
The study sites were two public academic hospitals in the Johannesburg area, namely: the 
Chris Hani Baragwanath Academic Hospital (CHBAH) in Soweto and the Charlotte Maxeke 
Johannesburg Academic Hospital (CMJAH) in Parktown. These are referral hospitals in 
Johannesburg and are accessible to the public. Both hospitals have a specialised gastro 
intestinal tract (GIT) clinic frequented by all patients with GIT diseases, including all PDAC 
patients, for diagnostic and therapeutic services.   
2.3 Study population  
The principal study included participants older than 18 years. This secondary study used a 
selection of the principal study population but with its own set of inclusion and exclusion 
criteria as follows: 
Inclusion criteria 
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Patients >18 years, admitted at two public Johannesburg academic hospitals, with abdominal 
CT scans demonstrating PDAC and/or patients with cytological and/or histological 
diagnoses of PDAC from June 2013-December 2015.  
Exclusion criteria 
Patients who have not had a CT-scan.  
Controls  
A case-cohort sampling method allowed the selection of cases and controls independently 
but at same time. 
Inclusion criteria 
Patients >18 years, admitted at two public Johannesburg academic hospitals with abdominal 
CT scans demonstrating a normal pancreas. The controls included trauma patients, 
abdominal aortic aneurysm patients, and patients with acute abdomens from causes other 
than any cancer. The control group is a reflection of the study population with the exception 
of a normal pancreas. Controls were generally easily identified and they were cooperative. 
Controls resembled the PDAC cases with respect to their tendency to give complete and 
accurate information, thus reducing potential differences between cases and controls in the 
quality of their recall of past exposures. 
Exclusion criteria 
Patients who have not had a CT-scan. 
2.4  Sample size and power 
The power of the study at 80% using expected proportions of the smoking risk factor in the 
case group as 0.35, and control group as 0.20, at a 95% confidence level with an OR of 1.7 
yielded a sample size of approximately 278 (139 cases and 139 controls) for the period of 
June 2013- December 2015. Smoking was used as a risk factor for sample size calculation 
based on the odds ratio of 1.7 between smokers and non-smokers. 
 
2.5 Data collection 
Records of participant’s demographics, social and medical history was captured in REDCap 
and imported to Stata 13 and Excel as summarized in Figure 1. 
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Figure 1. Flow chart of proceedure embarked on for data collection 
 
 
 
 
 
 
 
 
 
 
 
 
 
Admission 
in hospital 
/outpatient
• Eligible participants were approached by a research 
nurse or study coordinator.
Consent
• Informed consent was obtained and a form was signed
• Structured questionnaire was administered by Reserach 
nurse/coordinator at the study site.
• all information was recorded in REDCap
REDCap 
import of 
data
• The datasets was de-identified to preserve anonymity, this was done 
automatically by REDCap upon retrieving information for analysis. 
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The following variables were used: 
Table 1. Exposure variables and measurements 
Exposure variable Field label Measurement 
Race Patient race  Black 
White 
Indian 
Coloured 
Other 
Gender 
 
Patient gender Female 
Male 
Age years 
 
Age at registration Mean 
SD 
Age 
 
Age category 20-29 
30-39 
40-49 
50-59 
60-69 
70-79 
80+ 
Schooling 
 
Highest level of education 
 
Never attended school 
Primary school 
Secondary school 
Further Education 
Birth place 
 
Province of birth Gauteng 
Mpumalanga 
Limpopo 
North West 
Free State 
KwaZulu-Natal 
Eastern Cape 
Northern Cape 
Western Cape 
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Other Country 
Employment status 
 
Current Employment No 
Yes 
Longest job employed 
 
Primary type of employment Construction & chemical 
Mining 
Manufacturing & Factory 
Engineering 
Drivers 
General worker 
Office & other 
Smoked 
 
Have you ever smoked 
cigarettes? 
No 
Yes 
Smoke now 
 
Do you smoke now? No 
Yes 
Smoke pack years 
 
Number of pack years Mean  
SD 
Smoke pack category 
 
Pack years category No (0) 
Very rare (1-10) 
Frequent(11-30) 
Very frequent(31-max) 
Smoke home  
 
Is there someone who 
smokes pipe/cigarettes at 
home? 
No 
Yes 
Smoke work Is there someone who 
smokes pipe/cigarettes at 
work? 
No 
Yes 
Snuff 
 
Do you use snuff? No 
Yes 
Frequency of snuff 
 
How often do you use snuff? No 
Frequently-daily 
Infrequently-2/3 times weekly 
Rarely-2/3 times monthly 
Chew tobacco Do you chew tobacco? No 
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  Yes 
Tobacco frequency 
 
How often do you chew 
tobacco 
No 
Frequently-daily 
Infrequently-2/3 times weekly 
Rarely-2/3 times monthly 
Alcohol  Have you ever drunk 
alcohol? 
No  
Yes  
Bought beer 
 
Do you drink bought beer?  No  
Yes 
Home brewed  
 
Do you drink home brewed 
beer?  
No  
Yes 
Bought spirits 
 
Do you drink bought spirits?  No  
Yes 
Home-made spirits  
 
Do you drink home-made 
spirits?  
No  
Yes 
Wine  
 
Do you drink wine? No  
Yes 
Audit score 
 
Sum of drinks containing 
alcohol, number of drinks 
per day and occasions of 6 or 
more drinks. 
No(0 drinks) 
Low (1-6 drinks) 
High (7-12drinks) 
Chronic illness Do you have any chronic 
illness? 
No  
Yes 
Diabetes  Do you have diabetes? No  
Yes 
Cancer Do you have cancer? No  
Yes 
Hypertension  Do you have hypertension? No  
Yes 
Vascular  Do you have vascular 
disease? 
No  
Yes 
Asthma Do you have asthma? No  
Yes 
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COPD Do you have COPD? No  
Yes 
HIV/AIDS Do you have HIV/AIDS? No  
Yes 
TB Do you have TB? No  
Yes 
Acute Pancreatitis Do you have Acute 
pancreatitis? 
No  
Yes 
Chronic Pancreatitis Do you have chronic 
pancreatitis? 
No  
Yes 
Hepatitis  Do you have hepatitis? No  
Yes 
Rheumatoid Arthritis Do you have rheumatoid 
arthritis? 
No  
Yes 
Other  Do you have other chronic 
illnesses? 
No  
Yes 
Red meat  Do you eat red meat? No 
yes 
Red meat week How many times a week do 
you eat red meat? 
No (0) 
Low (1-4) 
High (5-7) 
White meat  Do you eat white meat? No 
Yes 
White meat week How many times a week do 
you eat white meat? 
No (0) 
Low (1-4) 
High (5-7) 
Vegetables  Do you eat vegetables meat? No 
Yes 
Vegetable week How many times a week do 
you eat vegetables? 
No (0) 
Low (1-4) 
High (5-7) 
Fish  Do you eat fish meat? No 
Yes 
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Fish week How many times a week do 
you eat fish? 
No (0) 
Low (1-4) 
High (5-7) 
Fried Fish  What type of fish do you eat? No 
Yes 
Canned Fish  What type of fish do you eat? No 
Yes 
Fresh Fish  What type of fish do you eat? No 
Yes 
Sea food What type of fish do you eat? No 
Yes 
Cured food Do you eat cured food? No 
yes 
Cured food week How many times a week do 
you eat cured food? 
No (0) 
Low (1-4) 
High (5-7) 
Fried food week How many times a week do 
you eat fried food? 
No (0) 
Low (1-4) 
High (5-7) 
Maize meal Do you eat maize meal? No 
Yes 
Maize meal week How many times a week do 
you eat maize meal? 
No (0) 
Low (1-4) 
High (5-7) 
Other  
Functionality Karnofsky functional status 
score. 
100%-normal function 
90%-capable of normal 
80%-normal activity 
70%-cares for self 
60%-requires help 
50%-often requires help 
40%-disabled 
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Symptoms level What is patient’s ECOG 
score? 
0-asymptomattic 
1-symptomatic but ambulatory  
2-symptomatic, < 50% 
3-symptomatic, >50% 
4-bedbound 
BMI Body Mass Index Mean  
SD 
BMI category Body Mass Index category Missing (.) 
Underweight (min-18.5) 
Healthy(18.6-24.9) 
Overweight (25-29.9) 
Obese (30-35.9) 
Very obese (36-max) 
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2.6 Data management and analysis 
2.6.1 Data management  
A de-identified excel spread sheet was imported from the existing REDCap database 
(Harrisa, Taylorb et al. 2009). Using Stata software version 13, various commands assisted 
in cleaning the data. Data cleaning processes included checking for duplicates, missing 
values, recoding and categorising variables. This was a quality assurance process. 
2.6.2 Statistical analysis 
Table 2. Objectives of the study and corresponding analysis undertaken 
Objectives Analysis 
1. To describe demographic, social, 
hospital and dietary characteristics 
of patients with PDAC in two public 
academic hospitals in Johannesburg 
between June 2013 and 
December2015. 
 
Proportions and percentages gave summary 
of categorical variables. Differences were 
analysed using chi-squared test. Summary 
of continuous variables were by the mean 
and the standard deviation, or median with 
interquartile range. 
2. To assess the risk factors associated 
with patients diagnosed with PDAC 
in two public academic hospitals in 
Johannesburg between June 2013 
and December 2015. 
Odds ratios calculated using multiple 
unconditional logistic regression. The 
model applied backward analysis. 
Likelihood ratio test (LRT) tested for 
confounder or effect modifier or interaction 
assumptions through adjustment. 
 
From Table 2 all statistical test analysis were two sided z-test and p values <0.25 were 
statistically significant.  A p value <0.20 meant we rejected the null hypothesis and that the 
variables were the same in both cases and controls (Hosmer and Lemeshow 2000, Vittinghof, 
Glidden et al. 2004).  
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2.7 Ethical considerations 
The Human Research Ethics Committee of the University of the Witwatersrand approved 
the primary study and participants signed an informed consent. The original ethical approval 
was in 2013 (Clearance Certificates M1305 50 & 51). The Wits Human Research Ethics 
Committee approved additional ethics for secondary data analysis (Clearance Certificate 
M160247) Figure 4. There was no personal identification in the dataset provided and a 
unique ID number from REDCap identified each patient. For this secondary data analysis, 
the principal investigator granted access to the data in the form of an approval letter and this 
is in Figure 2 and Figure 3. 
2.8 Study Budget 
The National Research Foundation (NRF) funded the initiation of the principal study. The 
grant number was 91508 with reference number CSUR13091741850 NRF South Africa. The 
South African Medical Research Council through a grant awarded to the Wits Common 
Epithelial Cancer Research Centre provided further funding for continuation of the principal 
study. Both grants allowed the development of the REDCap database that facilitated this 
research. 
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3. Results  
3.1 Introduction 
The study explored risk factors associated with PDAC at two Johannesburg academic 
hospitals between 2013 and 2015. This chapter shows the results obtained from the data 
analysis for both cases and controls.  
Summary of the results: 
Eighty two percent of all participants were black. The age groups comprising the most cases 
were the 50-59 and the 60-69 year olds. Most of the participants’ had a secondary level 
school education, and the longest jobs held were that of general workers  
 
Table 3. Cases had a higher percentage of smoke pack years per category as well as higher 
alcohol consumption compared to controls Table 5. However, smoking and alcohol had no 
statistical significance in our study. The functional status of the participants was in the 80-
90% normal function category. More than 27% of the Body Mass Index (BMI) information 
was missing. After unconditional multiple-logistic regression, the younger age group was 
less likely to be at risk of PDAC. White meat and vegetables per week showed a protective 
effect against PDAC while red meat consumption showed no statistical significance for the 
study population Table 6.  
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Description of study population: 
 
Table 3 Baseline characteristics 
 
Overall (n=278) Control (n=139) Case (n=139) 
Age years  
   
Mean 54.93 51.94 57.93 
SD 14.31 16.07 11.59 
Age  
   
20-29 16(6%) 15(11%) 1(1%) 
30-39 36(13%) 27(19%) 9(6%) 
40-49 34(12%) 17(12%) 17(12%) 
50-59 84(30%) 32(23%) 52(37%) 
60-69 69(25%) 28(20%) 41(30%) 
70-79 27(10%) 14(10%) 13(9%) 
80+ 12(4%) 6(4%) 6(4%) 
Race    
  
Black 228(82%) 114(82%) 114(82%) 
White 21(8%) 9(6%) 12(8%) 
Indian 9(3%) 5(4%) 4(3%) 
Coloured 18(8%) 10(7%) 8(6%) 
Other 2(1%) 1(1%) 1(1%) 
Gender  
   
Female 141(51%) 80(58%) 61(44%) 
Male 137(49%) 59(42%) 78(56%) 
Employed  
   
No 207(74%) 106(76%) 101(73%) 
Yes 71(26%) 33(24%) 38(27%) 
Longest job employed 
   
Construction & chemical 16(6%) 6(4%) 10(7%) 
Mining 6(2%) 2(1%) 4(3%) 
Manufacturing & Factory 26(9%) 17(12%) 9(7%) 
Engineering 12(4%) 8(6%) 4(3%) 
Drivers 20(7%) 7(5%) 13(9%) 
General worker 83(30%) 33(24%) 50(36%) 
Office & other 115(41%) 66(48%) 49(35%) 
Chronic illness 
   
No 115(41%) 57(41%) 58(42%) 
Yes 163(59%) 82(59%) 81(58%) 
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Table 4 Diet 
 Overall (n=278) Control (n=139) Case (n=139) 
Red meat week 
   
No 37(13%) 20(14%) 17(12%) 
Low 214(77%) 109(79%) 105(76%) 
High 27(10%) 10(7%) 17(12%) 
White meat week 
 
  
No 15(5%) 6(4%) 9(7%) 
Low 208(75%) 98(71%) 110(79%) 
High 55(20%) 35(25%) 20(14%) 
Vegetable week 
   
No 22(8%) 6(4%) 16(11%) 
Low 138(50%) 63(45%) 75(54%) 
High 118(42%) 70(51%) 48(35%) 
Fish week 
 
  
No 61(22%) 37(27%) 24(17%) 
Low 211(76%) 97(70%) 114(82%) 
High 6(2%) 5(3%) 1(1%) 
Cured food week 
   
No 130(47%) 64(46%) 66(47%) 
Low 143(51%) 70(50%) 73(53%) 
High 5(1%) 5(4%) 0 
Fried food week 
   
No 62(22%) 23(17%) 39(28%) 
Low 197(71%) 105(76%) 92(66%) 
High 19(7%) 11(7%) 8(6%) 
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Table 5 Social characteristics 
Audit score 
   
No 193(69%) 103(74%) 90(65%) 
Low 67(24%) 31(22%) 36(26%) 
High 18(7%) 5(4%) 13(9%) 
Smoked 
   
No 125(45%) 70(50%) 84(60%) 
yes 153(55%) 69(50%) 55(40%) 
Smoke now 
   
No 211(76%) 108(78%) 103(74%) 
Yes 67(24%) 31(22%) 36(26%) 
Smoke pack years 
   
Mean 9.09 7.27 10.9 
SD 16.31 14.52 17.79 
Smoke pack category 
   
No 136(50%) 78(56%) 58(41%) 
Very rare 72(26%) 34(24%) 38(27%) 
Frequent 43(15%) 17(12%) 26(19%) 
Very frequent 27(9%) 10(8%) 17(12%) 
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3.1.1 Demographic characteristics of study population 
Table 7 in the appendix explains the entire demographic characteristics. The study 
population included 278 participants. The youngest study participant (cases plus controls) 
was 23.8 years old, the oldest participant was 92.8 years old, and the mean age was 54.9 
years with a SD of 14.31. The mean age for controls was 51.94 years with a SD of 16.07 
while for the cases the mean age was 57.93 years with a SD 11.59. Participants belonged to 
the following races: black, coloured, Indian, white, and others. The majority of participants 
fell within the 50-59 age group and represented 30% of the total study population. In this 
age group, there were 32 controls and 52 cases. The majority of participants represented by 
race were black making up 82% of the total study population, thus in both case and control 
groups the number of black participants was 114 of the total. The majority of participants 
were born in the following provinces: Gauteng (48%), North West (10%), and Free State 
(9%). The level of education was highest for secondary schooling 138 (50%). The majority 
of participants were unemployed making up 74% of the total study population and of those 
who had worked the longest employment was that of the general worker and office/other 
category each contributing about 30% and 41% respectively of the total study population.   
 
3.1.2 Social characteristics of study population 
Table 8 in the appendix explains the social habits of the study population. Fifty five percent 
of the total study population smoked with the study cases having a mean smoke pack years 
of 10.90 and a SD of 17.79. This table shows that 64 control participants had drunk alcohol 
while on the other hand 88 case participants had drunk alcohol. Consumption of bought beer 
(i.e. factory-brewed beer) was the highest in both cases and controls with 57 and 45 
participants respectively. Of the total study population, 18% had high alcohol consumption 
and within groups, the consumption was 13% for cases and 5% for controls. 
 
3.1.3 Chronic Medical characteristics of study population 
Table 9 in the appendix shows the additional chronic medical conditions the participants 
had besides PDAC. The study population had 14% of participants with diabetes, 35% with 
hypertension and 17% with HIV/AIDS. Of these three chronic medical conditions, diabetes 
was present in 16% of cases compared to the 12% for controls. 
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3.1.4 Dietary characteristics of study population 
Table 10 in the appendix shows the entire dietary characteristics of the study population. 
Low consumption of red meat and white meat made up 214 (77%) and 208 (75%) of the 
entire study population respectively. Within the cases and controls, the low consumption of 
red and white meat group had an almost equal percentage above 70%. Error! Reference 
source not found. below shows high consumption of vegetables and maize meal recorded 
as 42% and 54% respectively for the entire study population. 
 
3.1.5 Hospital characteristics for the study population 
Table 11 in the appendix shows that 50 control group participants were capable of 90% 
normal activity while 47 of the case group had 80% normal activity. The ambulatory 
symptom level category had the majority of participants at 75 controls and 85 cases 
respectively, making up 58% of the total study population. 
 
3.2.1 Adjusted and unadjusted demographic factors associated with PDAC 
Table 12 in the appendix shows that the odds ratio of PDAC before adjustment in males was 
1.73 but after adjustment, it was insignificant. The odds ratio of PDAC in the 20-39 age 
group was below one showing protection in the young age group while the odds ratio was 
approximately three in the age group 50-69. The general workers odds ratio for PDAC was 
approximately two before and after adjustment. 
 
3.2.3 Adjusted and unadjusted dietary factors associated with PDAC 
Table 14 in the appendix shows the following unadjusted factors with weak significance and 
the corresponding odds ratios as follows:  white meat 0.38 in the high consumption category, 
vegetables 0.26 in the high intake category, fish 1.81 in the low intake category, fried foods 
0.52 in the low intake category and maize meal 0.22 in the high intake category. After 
adjustment, the following factors were significant: high consumption white meat per week 
0.14, low fish intake per week 2.15, low fried foods consumption per week 0.47, and high 
vegetable intake per week 0.13. 
 
3.2.3 Adjusted and unadjusted social factors associated with PDAC 
Table 15 in the appendix shows the odds ratio of PDAC before adjustment for smoke pack 
category to be 2.06 in frequent smoking, and 2.98 for high number of alcohol drinks (audit 
score) but after adjusting, both these factors were insignificant. 
0405483M 
 
25 | P a g e  
 
 
3.2.4 Adjusted and unadjusted hospital factors associated with PDAC 
Table 16 in the appendix shows the hospital characteristics of the study population where 
the odds ratio of PDAC in the 90% and 80% normal activity was 1.19 and 3.44 respectively. 
 
3.2.5 Final model  
Table 17 shows the final model for my study population. The odds ratios of PDAC in the 
20-29 age group was 0.11, in the 50-59 age group was 2.63 and in the 60-69 age group, it 
was 2.85. The odds ratio of PDAC for general workers was 1.79.  High white meat 
consumption had an odds ratio of 0.18 for PDAC. Low fish consumption per week shows an 
odds ratio of 2.17. The odds ratio for low fried foods consumption per week was 0.48 and 
high consumption of vegetables per week had an odds ratio of 0.17 for PDAC. 
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Table 6 Unadjusted and Adjusted OR for PDAC 
  
Characteristic UOR(95%CI) p-value AOR(95%CI) p-value 
Gender  
 
0.0224 
 
0.6992 
Female 1 (base) 1(base) 
Male 1.73 (1.07-2.79) 1.49(0.73-3.06) 
Age years  1.03(1.01-1.05) 0.0004 
  
Age  
 
0 
 
0.0006 
20-29 0.07 (0.008-0.56) 0.11(0.01-1.06) 
30-39 0.33(0.12-0.92) 0.60(0.19-1.90) 
40-49 1(base) 1(base) 
50-59 1.63(0.72-3.63) 2.61(1.00-6.78) 
60-69 1.46(0.64-3.35) 3.04(1.10-8.34) 
70-79 0.93(0.34-2.55) 1.58(0.49-5.11) 
80+ 1(0.27-3.73) 1.87(0.42-8.31) 
Long Employment  
 
0.037 
 
0.0419 
Construction & 
chemic 
2.24(0.76-6.59) 2.08(0.59-7.37) 
Mining 2.69(0.47-15.30) 1.70 (0.24-12.16) 
Manufacturing & 
Factory 
0.71(0.29-1.73) 0.49(0.17-1.40) 
Engineering 0.67(0.19-2.36) 0.30(0.07-1.28) 
Drivers 2.50(0.93-6.73) 1.95(0.60-6.35) 
General worker 2.04(1.15-3.62) 1.83(0.93-3.63) 
Office & other 1 (base) 1 (base) 
Red meat week 
 
0.3406 
 
0.9043 
No 1(base) 1(base) 
Low 1.13(0.56-2.28) 0.99(0.42-2.31) 
High 2.00(0.73-5.51) 1.13(0.33-3.92) 
White meat week 
 
0.0659 
 
0.0502 
No 1(base) 1(base) 
Low 0.75(0.26-2.18) 0.28(0.06-1.31) 
High 0.38(0.12-1.23) 0.14(0.03-0.73) 
Vegetable week 
 
0.0071 
 
0.0037 
No 1(base) 1(base) 
Low 0.45(0.16-1.21) 0.25(0.07-0.89) 
High 0.26(0.09-0.70) 0.13(0.04-0.49) 
Fish week 
 
0.0291 
 
0.0229 
No 1(base) 1(base) 
Low 1.81(1.01-3.24) 2.15(1.04-4.45) 
High 0.31(0.03-2.80) 0.17(0.01-2.78) 
Fried food week 
 
0.0636 
 
0.07 
No 1(base) 1(base) 
Low 0.52(0.29-0.93) 0.47(0.22-0.96) 
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High 0.43(0.15-1.22) 0.39(0.11-1.35) 
Smoke pack category 
 
0.0749 
 
0.7667 
No 1(base) 1(base) 
Very rare 1.50(0.85-2.67) 1.43(0.66-3.08) 
Frequent 2.06(1.02-4.14) 0.91(0.36-2.28) 
Very frequent 2.29(0.98-5.36) 1.10(0.38-3.19) 
Audit score 
 
0.0849 
 
0.2135 
No 1 (base) 1(base) 
Low 1.33(0.76-2.32) 1.62(0.78-3.35) 
High 2.98(1.02-8.67) 3.17(0.79-12.69) 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0405483M 
 
28 | P a g e  
 
4. Discussion  
4.1 Introduction  
Secondary analysis of data collected over 18 months (June 2013-December 2015) was done 
for a case-control study aimed at exploring the various risk factors associated with PDAC at 
two public academic hospitals in Johannesburg. The study population totalled 278, with 50% 
participants for both cases and controls. The main objectives of this study were, to describe 
the demographic characteristics of patients with PDAC and to assess the risk factors 
associated with patients diagnosed with PDAC in two public academic hospitals in 
Johannesburg between June 2013 and December2015.  
Mean and standard deviations for continuous data and proportions and percentages for 
categorical data was used to describe the demographic characteristics of patients with PDAC. 
Univariate and multivariate analyses were done using unconditional multiple logistic 
regression to assess the relationships and associations. Continuous variables were analysed 
inferentially as categorical to avoid clinically distorted OR at 95% CI and a coefficient slope 
of zero (Hosmer and Lemeshow 2000). Fitting a logistic model predicted risk of binary 
outcomes given a set of risk factors. The models isolated single predictors by incorporating 
other predictors to give clear interpretations of variable effects on the outcome (Vittinghof, 
Glidden et al. 2004).  The models assisted in identifying patients likely to have or not have 
limitations for future patient management costs. After performing univariate analysis, the 
variables with a p-value of <0.25 (Hosmer and Lemeshow 2000) were added into the full 
model for multivariable selection. This selection assisted in having the best model within the 
scientific context of the PDAC problem. Clinical and intuitive variables were selected 
regardless of their statistical significance (p-value <0.25 and >0.05) and included so as to 
control for confounding factors and to avoid losing important variables (Hosmer and 
Lemeshow 2000). Multiple odds ratios were estimated during the development of the 
predictive model. For the final model the p-value for the LR test was 0.20 (Hosmer and 
Lemeshow 2000).  All the analysis was done using STATA 13. 
With this study, we were able to identify the different exposures for rare PDAC disease. As 
this was a hospital-based population, only a small catchment area was covered and since 
patients’ details are de-identified, duplication or multiple counting can occur if patients were 
in different hospitals, as there may be no linking system. The population is standardized thus 
it is difficult to compare findings to a different setting.  Overall, the hospital-based 
population was good for the case-control study design.  
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In conclusion, the higher percentage/proportions was being male, consumed alcohol, 
smoked and being between the ages of 50-69. Being 50-69 years of age and employed for 
longer periods as the norm for a general worker was positively associated with PDAC. 
Additionally, increased consumption of vegetables and white meat was protective for PDAC, 
whilst a low intake of fish increased PDAC risk. 
A detailed discussion of the socio-demographic characteristics and risk factors are to follow 
under the following sub-headings: 
4.1.1 Demographic characteristics of patients with PDAC 
The study showed the most PDAC cases in the age category 50-59 years, while compared to 
other described studies, the age 60+ or even 70+ categories had the highest prevalence of 
PDAC cases. This indicates that this study’s PDAC patients were younger compared to other 
studies (Babb 2011, Yeo 2015). This may be due to the lower life expectancy of 
approximately 60 years in South Africa compared to in the developed countries.  In the 2011 
cancer registry, the highest PDAC percentage was in the 60-69 age group followed by the 
50-59 age group (Babb 2011). However, when comparing quantitative analysis performed 
for PDAC, the age range of 50-69 is when most incidences occur (Meza, Jeon et al. 2008), 
which is in agreement with this study results. Most of this study population attained 
secondary education and were born in the Gauteng province. Gauteng province is the 
economic hub of South Africa. Most people reside in Gauteng for employment opportunities 
and the two academic referral hospitals used in this study are in this province. Long 
employed general workers, office and other workers account for more than 30% of our study 
population.  The general workers included domestic workers, housewives, cleaners and 
gardeners. Furthermore, in this study, the longest employed general workers were affected 
mostly, which is also different from other studies in which industrial plant workers and 
chemical/pesticide workers were more at risk of developing PDAC (Yeo 2015). The general 
workers have a higher risk of developing PDAC since they are likely to be of low economic 
status, which may deprive them of quick access to health services or they may not have 
sufficient education to be cautious about their health and lifestyle. This is in stark contrast 
to most published studies which show that the occupations and factors which include: dry 
cleaning, chemical plant work, sawmills, electrical equipment, Ashkenazi Jewish heritage, 
manufacturing workers, miners and metal workers are more at risk of developing PDAC 
(Yeo and Lowenfels 2012, Yeo 2015).  
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 4.1.2 Social characteristics of study population 
The smoke pack category was not significant after adjusting and this may be because 
approximately 25% of the study population smoked a lot (frequently and very frequently), 
while the rest of the study population (75%) did not smoke. A lower number of participants 
indicated a high consumption of alcohol (in the audit score) and therefore, the adjustment 
made the alcohol variable statistically insignificant. Different chronic illnesses were mostly 
not significant. This insignificance may be because less than 15% of participants had other 
chronic conditions.  
In most studies the PDAC cases smoked more than the controls (Talamini, Polesel et al. 
2009), which corresponds with our study in which more cases smoked and additional  smoke 
exposure was from someone else who smoked at work.  Sixty-three percent of the cases 
consumed alcohol, which indicates just how alcohol is an independent risk factor for PDAC 
if the individual is a smoker (Talamini, Polesel et al. 2009).  In this study, smoking and 
alcohol consumption before adjusting were statistically significant when looking at the 
variable and outcome relationship. Adjusting for the potential confounding variables 
stripped away the effects of these factors in the relationship of the main variable and 
outcome.  
4.1.3 Medical/hospital characteristics 
More than 50% of our cases had other medical conditions of which among the top of the list 
was hypertension, diabetes and HIV/AIDS. Most published studies show diabetes, acute 
pancreatitis, HIV/AIDS, chronic pancreatitis and hepatitis B as additional medical 
conditions (Yeo and Lowenfels 2012, Ilic and Ilic 2016). In the three above-mentioned 
chronic medical conditions recorded in the study, the application of logistic regression did 
not yield any statistical significance values, showing that case and control medical conditions 
do not have an effect on the likelihood of developing PDAC. The study results may just be 
by chance or a larger sample size is required. Due to the HIV/AIDS stigma in South Africa, 
participants may have provided biased information that could have affected our results 
(Singh, Ruff et al. 2015).  
 
4.1.4 Dietary pattern of study population 
This study shows the proportion of the low consumption vs. the high consumption in the 
following variables: red meat, cured foods, fried foods and fish per week. The high 
consumption proportion was less than 10% in these variables. The following variables had 
close to or just above 20% in the high consumption per week: white meat, maize meal and 
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vegetables. The high consumption in the above-mentioned variables except for maize meal 
complements most literature (Lu, Shu et al. 2017). High consumption of white meat and 
vegetables are foods recommended for prevention of most cancers and lifestyle diseases at 
large. White meat per week, particularly in cases of high consumption shows a protective 
effect and this may be due to having less saturated fats compared to red meat. Low 
consumption of fish per week mostly seems to be a risk factor for PDAC. This finding may 
be due to the preparation method of the fish or it may simply be by chance. Low consumption 
of fried foods per week was protective. This may be due to the type of oil used and by not 
frying the foods at extremely high temperatures. In agreement with published studies, 
vegetables had a protective effect. Vegetables are high in antioxidants and cancer 
preventative nutrients. Therefore, high consumption of vegetables per week will have a 
protective effect against PDAC.  
 
4.2 Risk factors for patients with PDAC 
4.2.1 Age and Gender 
The age category 20-29 had a 0.10 odds ratio of PDAC with a p-value of <0.05, suggesting 
that people in this age group are less likely to get PDAC. On the other hand, for age 
categories 50-59 and 60-69 the odds ratios of PDAC are 2.49 and 2.96 respectively with p-
values of less than 0.1 indicating a greater risk of developing PDAC. These observations 
correlate with published literature stating how an increase in age, increase the risk of PDAC 
development by two to three times. Due to the improved life expectancy of populations 
globally, the number of aged individuals is on the rise. This rise indirectly increases the 
incidences of PDAC in these age groups (Fest, Ruiter et al. 2016). Furthermore, in a study 
using the Bayesian model for the top 20 risk factors, the age of 60+ ranked  in the top 10 risk 
factors on the list (Zhao and Weng 2011), for developing PDAC. Gender was statistically 
insignificant after adjusting and this was different from other studies in which the male race 
was shown to be associated with PDAC compared to woman. This may be due to the increase 
in the number of women who are now smoking in South Africa, unlike in the past where 
smoking was mostly associated with men. 
4.2.2 Alcohol 
Alcohol consumption in high quantities was a top risk factor in the Bayesian model and this 
also agrees with our unadjusted results (Zhao and Weng 2011). Review  done around 2005 
showed no association of high alcohol consumption and PDAC (Lowenfels and 
Maisonneuve 2006), and this was confirmed by  our adjusted results.  
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4.2.3 Diet  
4.2.3.1 White meat and red meat 
High consumption of white meat per week shows a protective effect with an odds ratio of 
0.18. This concur with the benefit of regulated healthy dietary requirements compared to red 
meat consumption per week (Larsson, Hakanson et al. 2006, Lu, Shu et al. 2017). White 
meat may have a protective effect due to less saturated fat content and upon cooking, it may 
release minimal nitrosamines compared to red meat. The number of cases and controls 
consuming red meat was approximately the same and this might be why this category 
showed no significance during the logistic regression analysis. In a review paper by Zhao et 
al. (2016) the effects of red meat and processed food consumption was inconclusive (Zhao, 
Yin et al. 2016). 
4.2.3.2 Fish  
While low fish consumption per week has an odds ratio risk of 2.17, the observed risk of 
PDAC with fish consumption could be due to the way the fish is prepared, such as deep-
fried, which reduces the amount of LC-PUFA in fish and generates several chemicals that 
may contribute to carcinogenesis (Pericleous, Rossi et al. 2014).   
4.2.3.3 Fried foods 
Low fried food consumption per week has a protective effect of 0.48 which  may be due to 
the use of saturated or monounsaturated fatty acids (Nkondjock, Krewski et al. 2005) as seen 
in the  study population. 
4.2.3.4 Vegetables  
General consumption of vegetables has a protective effect, but this protective effect was 
enhanced with increased vegetable consumption showing an odds ratio of 0.17. This finding 
support the other studies on the protection of vegetables in PDAC diagnosis, and it may 
show that specific vegetables consumed by study participants brought about this effect 
(Nöthlings, Wilkens et al. 2007). 
 
4.2.4 Employment 
In the long employment category, the general workers had a 1.79 times odds ratio for PDAC 
with a resultant p-value of 0.083. In the 1970s occupational factors such as chemicals and 
pesticides for example, were suspected to be risk factors for PDAC, but no proof was 
available, however in around 2005 occupation was not regarded a major  risk factor for 
developing PDAC (Lowenfels and Maisonneuve 2006).  
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4.3 Study limitations 
 The primary study focused on the genetic and environmental factors that influence 
susceptibility to PDAC, which in itself did not answer the questions of this particular 
study.  
 This study used secondary data. Records did not have all the relevant information 
required for our study, as most values such as BMI were missing. 
 Due to the study being a case-control study, there were difficulties in overcoming 
potential bias due to the recall or interviewer bias. 
 Adjustment of confounders occurred during the analysis stage and not at the design 
stage or by matching. 
 The successful selection of both cases and controls representative of respective 
populations was difficult, since in our study was hospital based. 
 Inference to causality and inadequate data on the chronology of disease and exposure 
was a problem, considering that this was a retrospective directional study. 
 The study was not population based, therefore, it is impossible to calculate incidence 
of disease since no total population statistics were included.  
 Even though there were some limitations, this study design is good for rare diseases 
like PDAC, and multiple exposures for one outcome allow for checking multiple 
associations. 
 A major disadvantage of the control group selected from diseased individuals is that 
some of their illnesses may have shared risk factors with the cases, meaning that they 
may have a higher, or lower, exposure prevalence compared to the population from 
which the cases arose. 
 The ORs measured exposure to the disease and not the disease occurrence.  
 In some variables, there was a wide confidence interval due to the sample size being 
very low in those variables. This is an indication of a larger sample size required. 
 Dietary assessment could have been biased as the assessment could have been done 
while the subject was following a diet prescribed by physician. The norm for 
recalling patterns should be a healthy lifestyle. 
 The hospital based patient data was collected in the hospital, but the catchment 
population was not defined and the data collection was mostly for administrative 
purposes. 
0405483M 
 
34 | P a g e  
 
5. Conclusions and recommendations  
5.1 Introduction  
This final chapter gives the conclusions, recommendations and future studies that can add 
valuable information to the epidemiology of PDAC. 
5.2 Conclusions  
This research showed how many people had PDAC in the period of June 2013 to December 
2015 in the two academic hospitals. Age of diagnosis for most cases (50-59) and the birth 
province where most cases were born (Gauteng) was identified. The black population had 
the most cases and the male to female ratio was 1.3: 1. In this study, the factors that posed 
risks for development of PDAC were older age, low consumption of fish and long 
employment as a general worker. The following weekly diet showed protection against 
PDAC, high consumption of white meat and vegetables. With the information from this 
study, identification of whether a particular dietary component influences the risk of 
developing PDAC was established. Identification of the answers in a public setting gives 
motivation to check reproducibility of results in the private sector. The results can further 
assist an individual’s daily decisions such as to stop smoking and to eat more vegetables, as 
this affect their health over a lifetime. As the principal study continues, we may be able to 
analyse historical trends and current data to project future public health resource needs for 
PDAC management. 
5.3 Recommendations  
The evidence presented in this study suggests that a greater emphasis on economic policies 
focusing on assisting the poor and marginalised communities is needed in the discourse of 
PDAC control. This is due to the public hospitals having a patient booking system that may 
take as long as six months or more before the doctor can see a patient. This long period can 
also be causative of advanced stage diagnosis of PDAC. This study confirms that age is 
associated with a significant increase in the risk of developing PDAC. There is a need to 
strengthen the implementation of a better and well-managed lifestyle as an individual age. 
These include physical activity, improving nutrition and hygiene, as well as improving 
access to health services. Active periodical case finding among the symptomatic and close 
contact of the index cases is recommended. Further research on risk factors for PDAC to 
address the limitations of this study will describe the burden in a large community for public 
health priorities. PDAC prevention strategies should focus on interventions that reduce or 
limit the impact of its risk. With a well-functioning population-based registry, good 
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monitoring and assessment of effectiveness of cancer control activities is possible, opposed 
to the current hospital-based information only. 
5.4 Future studies 
Collaboration with both public and private hospitals for a complete report of incidence and 
prevalence of PDAC across South Africa can add value to these study results. Knowing that 
South Africa is a poor resourced country, the cost of illness due to PDAC may assist in the 
resource allocation during the national budget allocation process. Further studies regarding 
the cost of illness may be determined by the period from admission to diagnosis and all the 
tests and equipment used for diagnosis of PDAC. The years of life lost to ill health will give 
an overall picture of the significance of this disease to the society beyond the immediate cost 
of treatment. Further studies on behaviour related to health and well-being, for example 
whether exercise has an effect on PDAC would be of great value in future. 
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7. Appendix 
 
Figure 2 Letter from the gatekeeper 
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Figure 3 Letter to the gatekeeper 
 
0405483M 
 
43 | P a g e  
 
 
 
 
0405483M 
 
44 | P a g e  
 
Figure 4 Ethic clearance 
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Table 7 Demographic characteristics of study population  
Characteristics  Overall (n=278) Control (n=139) Case (n=139) 
Race  
Black 
White 
Indian 
Coloured 
Other 
  
228(82%) 
21(8%) 
9(3%) 
18(8%) 
2(1%) 
 
114(82%) 
9(6%) 
5(4%) 
10(7%) 
1(1%) 
 
114(82%) 
12(8%) 
4(3%) 
8(6%) 
1(1%) 
Gender  
Female 
Male 
 
141(51%) 
137(49%) 
 
80(58%) 
59(42%) 
 
61(44%) 
78(56%) 
Age years  
Mean  
SD 
 
54.93 
14.31 
 
51.94 
16.07 
 
57.93 
11.59 
Age  
20-29 
30-39 
40-49 
50-59 
60-69 
70-79 
80+ 
 
16(6%) 
36(13%) 
34(12%) 
84(30%) 
69(25%) 
27(10%) 
12(4%) 
 
15(11%) 
27(19%) 
17(12%) 
32(23%) 
28(20%) 
14(10%) 
6(4%) 
 
1(1%) 
9(6%) 
17(12%) 
52(37%) 
41(30%) 
13(9%) 
6(4%) 
Schooling 
Never attended school 
Primary school 
Secondary school 
Further Education  
 
27(10%) 
97(35%) 
138(50%) 
16(5% 
 
12(9%) 
40(29%) 
77(55%) 
10(7%) 
 
15(11%) 
57(41%) 
61(44%) 
6(4%) 
Birth place  
Gauteng 
Mpumalanga 
Limpopo 
North West 
Free State 
 
134(48%) 
15(5%) 
14(5%) 
27(10%) 
25(9%) 
 
66(47%) 
7(5%) 
5(4%) 
12(9%) 
11(8%) 
 
68(49%) 
8(6%) 
9(6%) 
15(10%) 
14(10%) 
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KwaZulu-Natal 
Eastern Cape 
Northern Cape 
Western Cape 
Other Country 
21(8%) 
14(5%) 
4(1%) 
2(1%) 
22(8%) 
10(7%) 
9(6%) 
4(3%) 
1(1%) 
14(10%) 
11(8%) 
5(4%) 
0 
1(1%) 
8(6%) 
Employed  
No 
Yes 
 
207(74%) 
71(26%) 
 
106(76%) 
33(24%) 
 
101(73%) 
38(27%) 
Longest job employed 
Construction & chemical 
Mining 
Manufacturing & Factory 
Engineering 
Drivers 
General worker 
Office & other 
 
16(6%) 
6(2%) 
26(9%) 
12(4%) 
20(7%) 
83(30%) 
115(41%) 
 
 
6(4%) 
2(1%) 
17(12%) 
8(6%) 
7(5%) 
33(24%) 
66(48%) 
 
10(7%) 
4(3%) 
9(7%) 
4(3%) 
13(9%) 
50(36%) 
49(35%) 
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Table 8Social characteristics of study population 
Characteristic  Overall (n=278) Control (n=139) Case (n=139) 
Smoked 
No 
yes 
 
125(45%) 
153(55%) 
 
70(50%) 
69(50%) 
 
84(60%) 
55(40%) 
Smoke now 
No 
Yes 
 
211(76%) 
67(24%) 
 
108(78%) 
31(22%) 
 
103(74%) 
36(26%) 
Smoke pack years 
Mean  
SD 
 
9.09 
16.31 
 
7.27 
14.52 
 
10.90 
17.79 
Smoke pack category 
No 
Very rare 
Frequent 
Very frequent 
 
136(50%) 
72(26%) 
43(15%) 
27(9%) 
 
78(56%) 
34(24%) 
17(12%) 
10(8%) 
 
58(41%) 
38(27%) 
26(19%) 
17(12%) 
Exposed to smoke at home 
No 
yes 
 
183(66%) 
95(34%) 
 
88(63%) 
51(37%) 
 
95(68%) 
44(32%) 
Exposed to smoke at work 
No  
Yes 
 
125(45%) 
153(55%) 
 
65(47%) 
74(53%) 
 
60(43%) 
79(57%) 
Snuff 
No 
Yes 
 
255(92%) 
23(8%) 
 
129(93%) 
10(7%) 
 
127(91%) 
12(9%) 
Frequency of snuff 
No 
Frequently-daily 
Infrequently-2/3 times weekly 
Rarely-2/3 times monthly 
 
256(92%) 
13(5%) 
5(2%) 
4(1%) 
 
129(93%) 
4(3%) 
3(2%) 
3(2%) 
 
127(91%) 
9(7%) 
2(1%) 
1(1%) 
Chew tobacco 
No 
yes 
 
270(97%) 
8((3%) 
 
136(98%) 
3(2%) 
 
134(96%) 
5(4%) 
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Tobacco frequency 
No 
Frequently-daily 
Infrequently-2/3 times weekly 
Rarely-2/3 times monthly 
 
270(97%) 
3(1%) 
4(1%) 
1(1%) 
 
136(98%) 
1(1%) 
2(1%) 
0 
 
134(96%) 
2(1.5%) 
2(1.5%) 
1(1%) 
Alcohol  
No 
Yes 
 
126(45%) 
152(55%) 
 
75(54%) 
64(46%) 
 
51(37%) 
88(63%) 
Bought beer 
No 
Yes 
 
176(63%) 
102(37%) 
 
94(68%) 
45(32%) 
 
82(59%) 
57(41%) 
Home brewed  
No 
Yes 
 
246(88%) 
32(12%) 
 
122(88%) 
17(12%) 
 
124(89%) 
15(11%) 
Bought spirits 
No 
Yes 
 
233(84%) 
45(16%) 
 
119(86%) 
20(14%) 
 
114(82%) 
25(18%) 
Home-made spirits  
No 
Yes 
 
271(97%) 
7(3%) 
 
134(96%) 
5(4%) 
 
137(99%) 
2(1%) 
Wine  
No 
Yes 
 
241(87%) 
37(13%) 
 
118(85%) 
21(15%) 
 
123(88%) 
16(12%) 
Audit score 
No 
Low 
High 
 
193(69%) 
67(24%) 
18(7%) 
 
 
103(74%) 
31(22%) 
5(4%) 
 
90(65%) 
36(26%) 
13(9%) 
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Table 9 Chronic Medical characteristics of the study population 
Characteristics  Overall (n=278) Control (n=139) Case (n=139) 
Chronic illness 
No 
Yes 
 
115(41%) 
163(59%) 
 
57(41%) 
82(59%) 
 
58(42%) 
81(58%) 
Diabetes  
No 
Yes 
 
239(86%) 
39(14%) 
 
122(88%) 
17(12%) 
 
117(84%) 
22(16%) 
Cancer 
No 
Yes 
 
271(97%) 
7(3%) 
 
138(99%) 
1(1%) 
 
133(96%) 
6(4%) 
Hypertension  
No 
Yes 
 
181(65%) 
97(35%) 
 
86(62%) 
53(38%) 
 
95(68%) 
44(32%) 
Vascular  
No 
Yes 
 
267(96%) 
11(4%) 
 
131(94%) 
8(6%) 
 
136(98%) 
3(2%) 
Asthma 
No 
Yes 
 
272(98%) 
6(2%) 
 
137(99%) 
1(1%) 
 
135(97%) 
4(3%) 
COPD 
No 
Yes 
 
276(99%) 
2(1%) 
 
138(99%) 
1(1%) 
 
138(99%) 
1(1%) 
HIV/AIDS 
No 
Yes 
 
230(83%) 
48(17%) 
 
115(83%) 
24(17%) 
 
115(83%) 
24(17%) 
TB 
No 
Yes 
 
273(98%) 
5(2%) 
 
137(99%) 
2(1%) 
 
136(98%) 
3(2%) 
Acute Pancreatitis 
No 
Yes 
 
278(100%) 
0 
 
139(100%) 
0 
 
139(100%) 
0 
Chronic Pancreatitis    
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No 
Yes 
277(100%) 139(100%) 
0 
138(99%) 
1(1%) 
Hepatitis  
No 
Yes 
 
278(100%) 
 
139(100%) 
0 
 
139(100%) 
0 
Rheumatoid 
Arthritis 
No 
Yes 
 
273(98%) 
5(2%) 
 
135(97%) 
4(3%) 
 
138(99%) 
1(1%) 
Other  
No 
Yes 
 
264(95%) 
14(5%) 
 
135(97%) 
4(3%) 
 
129(93%) 
10(7%) 
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Table 10Dietary characteristics of study population 
Characteristic  Overall (n=278) Control (n=139) Case (n=139) 
Red meat  
No 
yes 
 
26(9%) 
252(91%) 
11(8%) 
128(92%) 
15(11%) 
124(89%) 
Red meat week 
No 
Low 
High 
 
37(13%) 
214(77%) 
27(10%) 
 
20(14%) 
109(79%) 
10(7%) 
 
17(12%) 
105(76%) 
17(12%) 
White meat  
No 
Yes 
 
10(4%) 
268(96%) 
1(1%) 
138(99%) 
9(6%) 
130(94%) 
White meat week 
No 
Low 
High 
 
15(5%) 
208(75%) 
55(20%) 
6(4%) 
98(71%) 
35(25%) 
9(7%) 
110(79%) 
20(14%) 
Vegetables  
No 
Yes 
 
16(6%) 
262(94%) 
 
1(1%) 
138(99%) 
 
15(11%) 
124(89%) 
Vegetable week 
No 
Low 
High 
 
22(8%) 
138(50%) 
118(42%) 
 
6(4%) 
63(45%) 
70(51%) 
 
16(11%) 
75(54%) 
48(35%) 
Fish  
No 
Yes 
 
27(10%) 
251(90%) 
9(6%) 
130(94%) 
18(13%) 
121(87%) 
Fish week 
No 
Low 
High 
 
61(22%) 
211(76%) 
6(2%) 
37(27%) 
97(70%) 
5(3%) 
24(17%) 
114(82%) 
1(1%) 
Fried Fish  
No 
Yes 
 
195(70%) 
83(30%) 
90(65%) 
49(35%) 
105(76%) 
34(24%) 
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Canned Fish  
No 
Yes 
 
145(52%) 
133(48%) 
64(46%) 
75(54%) 
81(58%) 
58(42%) 
Fresh Fish  
No 
Yes 
 
100(36%) 
178(64%) 
37(27%) 
102(73%)) 
63(45%) 
76(55%) 
Sea food 
No 
Yes 
 
269(97%) 
9(3%) 
 
131(94%) 
8(6%) 
 
138(99%) 
1(1%) 
Cured food 
No 
Yes 
 
105(38%) 
173(62%) 
 
44(32%) 
95(68%) 
 
61(44%) 
78(56%) 
Cured food week 
No 
Low 
High 
 
130(47%) 
143(51%) 
5(1%) 
 
64(46%) 
70(50%) 
5(4%) 
 
66(47%) 
73(53%) 
0 
Fried food week 
No 
Low 
High 
 
62(22%) 
197(71%) 
19(7%) 
 
23(17%) 
105(76%) 
11(7%) 
 
39(28%) 
92(66%) 
8(6%) 
Maize meal 
No 
Yes 
 
21(8%) 
257(92%) 
4(3%) 
135(97%) 
17(12%) 
122(88%) 
Maize meal week 
No 
Low 
High 
Other  
 
21(7%) 
106(38%) 
150(54%) 
1(1%) 
4(3%) 
57(41%) 
78(56%) 
0 
17(12%) 
49(35%) 
72(52%) 
1(1%) 
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Table 11Hospital characteristics for the study population 
Characteristic  Overall (n=278) Control (n=139) Case (n=139) 
Functionality 
100%-normal function 
90%-capable of normal 
80%-normal activity 
70%-cares for self 
60%-requires help 
50%-often requires help 
40%-disabled 
 
60(22%) 
87(31%) 
69(25%) 
39(14%) 
10(4%) 
9(3%) 
4(1%) 
 
37(27%) 
50(36%) 
22(16%) 
15(11%) 
6(4%) 
6(4%) 
3(2%) 
 
23(17%) 
37(27%) 
47(34%) 
24(24%) 
4(3%) 
3(2%) 
1(1%) 
Symptoms level 
0-asymptomattic 
1-symptomatic but ambulatory  
2-symptomatic, < 50% 
3-symptomatic, >50% 
4-bedbound 
 
60(22%) 
160(58%) 
44(16%) 
11(4%) 
3(1%) 
 
37(27%) 
75(54%) 
19(14%) 
6(4%) 
2(1%) 
 
23(17%) 
85(61%) 
25(18%) 
5(4%) 
1(1%) 
BMI 
Mean 
SD 
N=185 
24.28 
7.59 
N=61 
25.61 
7.80 
N=124 
23.63 
7.43 
BMI category 
Missing 
Underweight 
Healthy 
Overweight 
Obese 
Very obese 
 
93(33%) 
41(15%) 
76(27%) 
29(10%) 
23(8%) 
16(6%) 
 
78(56%) 
11(8%) 
22(16%) 
10(7%) 
9(6%) 
9(6%) 
 
15(11%) 
30(22%) 
54(39%) 
19(14%) 
14(10%) 
7(5%) 
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Table 12Factors associated with PDAC 
Characteristic  UOR(95%CI) p-value AOR(95%CI) p-value 
Race  
Black 
White 
Indian 
Coloured 
Other 
 
1 (base) 
1.33(0.54-3.29) 
0.8(0.21-3.06) 
0.8(0.30-2.01) 
No values 
0.9432 † † 
Gender  
Female 
Male 
 
1 (base) 
1.73 (1.07-2.79) 
0.0224 
 
1(base) 
1.49(0.73-3.06) 
0.6992 
Age years  1.03(1.01-1.05) 0.0004   
Age  
20-29 
30-39 
40-49 
50-59 
60-69 
70-79 
80+ 
 
0.07 (0.008-0.56) 
0.33(0.12-0.92) 
1(base) 
1.63(0.72-3.63) 
1.46(0.64-3.35) 
0.93(0.34-2.55) 
1(0.27-3.73) 
0.0000 
 
0.11(0.01-1.06) 
0.60(0.19-1.90) 
1(base) 
2.61(1.00-6.78) 
3.04(1.10-8.34) 
1.58(0.49-5.11) 
1.87(0.42-8.31) 
0.0006 
Schooling 
Never attended school 
Primary school 
Secondary school 
Further Education  
 
1 (base) 
1.14(0.48-2.69) 
0.63(0.28-1.45) 
0.48(0.14-1.70) 
0.1023 † † 
Birth place  
Gauteng 
Mpumalanga 
Limpopo 
North West 
Free State 
KwaZulu-Natal 
Eastern Cape 
 
1 (base) 
1.11(0.38-3.23) 
1.75(0.56-5.49) 
1.21(0.53-2.79) 
1.24(0.52-2.92) 
1.07(0.43-2.68) 
0.54(0.17-1.69) 
0.7833 † † 
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Northern Cape 
Western Cape 
Other Country 
empty 
0.98(0.06-15.84) 
0.55(0.22-1.41) 
Employed  
No 
Yes 
 
1 (base) 
1.21(0.70-2.07) 
0.4915 † † 
Long Employment  
Construction & chemic 
Mining 
Manufacturing & Factory 
Engineering 
Drivers 
General worker 
Office & other 
 
2.24(0.76-6.59) 
2.69(0.47-15.30) 
0.71(0.29-1.73) 
0.67(0.19-2.36) 
2.50(0.93-6.73) 
2.04(1.15-3.62) 
1 (base) 
0.0370 
 
2.08(0.59-7.37) 
1.70 (0.24-
12.16) 
0.49(0.17-1.40) 
0.30(0.07-1.28) 
1.95(0.60-6.35) 
1.83(0.93-3.63) 
1 (base) 
0.0419 
† No values since the UOR was statistically insignificant  
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Table 13Chronic medical factors associated with PDAC 
Factor  UOR(95%CI) p-value AOR(95%CI) p-value 
Chronic illness 
No 
Yes 
 
1 (base) 
0.97(0.60-1.56) 
0.9031 
† † 
Diabetes  
No 
Yes 
 
1 (base) 
1.35(0.68-2.67) 
0.3873 
† † 
Cancer 
No 
Yes 
 
1 (base) 
6.23(0.74-52.41) 
0.0440 
∞ ∞ 
Hypertension  
No 
Yes 
 
1 (base) 
0.75(0.46-1.23) 
0.2572 
† † 
Vascular  
No 
Yes 
 
1 (base) 
0.36(0.09-1.39) 
0.1174 
† † 
Asthma 
No 
Yes 
 
1 (base) 
2.03(0.37-11.26) 
0.4047 
† † 
COPD 
No 
Yes 
 
1 (base) 
1.00(0.06-16.15) 
1.0000 
† † 
HIV/AIDS 
No 
Yes 
 
1 (base) 
1.00(0.54-1.86) 
1.0000 
† † 
TB 
No 
Yes 
 
1 (base) 
1.51(0.25-9.19) 
0.6507 
† † 
Acute Pancreatitis 
No 
Yes 
 
No values 
 
† † 
Chronic Pancreatitis No values  † † 
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No 
Yes 
Hepatitis  
No 
Yes 
No values  
† † 
Rheumatoid Arthritis 
No 
Yes 
 
1 (base) 
0.24(0.03-2.22) 
0.1615 
† † 
Other  
No 
Yes 
 
1 (base) 
2.62(0.80-8.55) 
0.0947 
‡ ‡ 
† No values since the UOR was statistically insignificant.  
∞The variable not added in the model as the cancer was in exclusion criteria.  
‡ AOR was statistically insignificant. 
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Table 14Dietary factors associated with PDAC 
Factor  UOR(95%CI) p-value AOR(95%CI) p-value 
Red meat  
No 
Yes 
 
1 (base) 
0.71(0.31-1.61) 
0.4091 
† † 
Red meat week 
No 
Low 
High 
 
1(base) 
1.13(0.56-2.28) 
2.00(0.73-5.51) 
0.3406 
 
1(base) 
0.99(0.42-2.31) 
1.13(0.33-3.92) 
0.9043 
White meat  
No 
Yes 
 
1 (base) 
0.10(0.01-0.84) 
0.0058 ⃰ ⃰ 
White meat week 
No 
Low 
High 
 
1(base) 
0.75(0.26-2.18) 
0.38(0.12-1.23) 
0.0659 
 
1(base) 
0.28(0.06-1.31) 
0.14(0.03-0.73) 
0.0502 
Vegetables  
No 
Yes 
 
1 (base) 
0.06(0.01-0.46) 
0.0001 ⃰ ⃰ 
Vegetable week 
No 
Low 
High 
 
1(base) 
0.45(0.16-1.21) 
0.26(0.09-0.70) 
0.0071 
 
1(base) 
0.25(0.07-0.89) 
0.13(0.04-0.49) 
0.0037 
Fish  
No 
Yes 
 
1 (base) 
0.47(0.20-1.08) 
0.0660 ⃰ ⃰ 
Fish week 
No 
Low 
High 
 
1(base) 
1.81(1.01-3.24) 
0.31(0.03-2.80) 
0.0291 
 
1(base) 
2.15(1.04-4.45) 
0.17(0.01-2.78) 
0.0229 
Fried Fish  
No 
Yes 
 
1 (base) 
0.44(0.26-0.72) 
0.0011 ⃰ ⃰ 
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Canned Fish  
No 
Yes 
 
1 (base) 
0.61(0.38-0.98) 
0.0410 ⃰ ⃰ 
Fresh Fish  
No 
Yes 
 
1 (base) 
0.59(0.35-1.00) 
0.0488 ⃰ ⃰ 
Sea food 
No 
Yes 
 
1 (base) 
0.12(0.01-0.96) 
0.0115 ⃰ ⃰ 
Cured food 
No 
Yes 
 
1 (base) 
0.59(0.36-0.97) 
0.0352 ⃰ ⃰ 
Cured food week 
No 
Low 
High 
 
1(base) 
1.01(0.63-1.63) 
Empty 
0.9632 † † 
Fried food week 
No 
Low 
High 
 
1(base) 
0.52(0.29-0.93) 
0.43(0.15-1.22) 
0.0636 
 
1(base) 
0.47(0.22-0.96) 
0.39(0.11-1.35) 
0.0700 
Maize meal 
No 
Yes 
 
1 (base) 
0.21(0.07-0.65) 
0.0023 ⃰ ⃰ 
Maize meal week 
No 
Low 
High 
Other  
 
1(base) 
0.20(0.06-0.64) 
0.22(0.07-0.68) 
Empty  
0.0086 ‡ ‡ 
† No values since the UOR was statistically insignificant.  
‡ AOR was statistically insignificant.  
* The multiple categories in the model and not the binary (yes/no) category. 
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Table 15Social factors associated with PDAC 
Factor  UOR(95%CI) p-value AOR(95%CI) p-
value 
Smoked 
No 
yes 
 
1 (base) 
1.55(0.96-2.49) 
0.0702 
* * 
Smoke now 
No 
Yes 
 
1 (base) 
1.21(0.70-2.11) 
0.4830 
*† *† 
Smoke pack years 
 
 
 
1.01(1.00-1.03) 0.0583 
∞ ∞ 
Smoke pack category 
No 
Very rare 
Frequent 
Very frequent 
 
1(base) 
1.50(0.85-2.67) 
2.06(1.02-4.14) 
2.29(0.98-5.36) 
0.0749 
 
1(base) 
1.43(0.66-3.08) 
0.91(0.36-2.28) 
1.10(0.38-3.19) 
0.7667 
Exposed to smoke at home 
No 
Yes 
 
 
1 (base) 
0.80(0.49-1.31) 
0.3759 
*† *† 
Exposed to smoke at work 
No  
Yes 
 
 
1 (base) 
1.16(0.72-1.86) 
0.5466 
*† *† 
Snuff 
No 
Yes 
 
1 (base) 
1.10(0.47-2.58) 
0.8276 
*† *† 
Frequency of snuff 
No 
Frequently-daily 
Infrequently-2/3 times weekly 
Rarely-2/3 times monthly 
 
1(base) 
2.29(0.69-7.61) 
0.68(0.11-4.12) 
0.34(0.03-3.30) 
0.3565 
† † 
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Chew tobacco 
No 
Yes 
 
1 (base) 
1.69(0.40-7.22) 
0.4708 
*† *† 
Tobacco frequency 
No 
Frequently-daily 
Infrequently-2/3 times weekly 
Rarely-2/3 times monthly 
 
1(base) 
2.03(0.18-22.65) 
1.01(0.14-7.31) 
Empty  
0.8390 † † 
Alcohol  
No  
Yes 
 
1 (base) 
2.02(1.25-3.27) 
0.0037 * * 
Bought beer 
No  
Yes 
 
1 (base) 
1.45(0.89-2.37) 
0.1350 † † 
Home brewed  
No  
Yes 
 
1 (base) 
0.87(0.42-1.82) 
0.7070 † † 
Bought spirits 
No  
Yes 
 
1 (base) 
1.30(0.69-2.48) 
0.4151 † † 
Wine  
No  
Yes 
 
1 (base) 
0.73(0.36-1.47) 
0.3767 † † 
Audit score 
No 
Low 
High 
 
1 (base) 
1.33(0.76-2.32) 
2.98(1.02-8.67) 
 
0.0849  
1(base) 
1.62(0.78-3.35) 
3.17(0.79-
12.69) 
0.2135 
*† No values since the UOR was statistically insignificant and the multiple category was added in the model and not the binary (yes/no) 
category. 
 ‡ AOR was statistically insignificant.  
∞ Categorical variable used in the model. 
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Table 16Hospital factors associated with PDAC 
Factor  UOR(95%CI) p-value AOR(95%CI) p-value 
Functionality 
100%-normal function 
90%-capable of normal 
80%-normal activity 
70%-cares for self 
60%-requires help 
50%-often requires help 
40%-disabled 
 
1 (base) 
1.19(0.61-2.33) 
3.44(1.66-7.10) 
2.57(1.12-5.90) 
1.07(0.27-4.21) 
0.80(0.18-3.53) 
0.54(0.05-5.47) 
0.0040 ₳ ₳ 
Symptoms level 
0-asymptomattic 
1-symptomatic but ambulatory  
2-symptomatic, < 50% 
3-symptomatic, >50% 
4-bedbound 
 
1 (base) 
0.75(0.20-2.73) 
1.36(0.40- 4.64) 
1.58(0.42-5.96) 
No values 
0.1846 † † 
BMI 0.97(0.93-1.01) 0.0991 ≠ ≠ 
BMI category 
Missing 
Underweight 
Healthy 
Overweight 
Obese 
Very obese 
 
0.08(0.04-0.16) 
1.11(0.47-2.60) 
1 (base) 
0.77(0.31-1.93) 
0.63(0.24-1.68) 
0.32(0.10-0.96) 
0.0000 ≠ ≠ 
† No values since the UOR was statistically insignificant.  
₳ Variable not added in the multivariate analysis as this could been a symptoms of illness.  
≠ Variable not added due to more than 10% missing data. 
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Table 17Final model 
Characteristics  AOR(95%CI) p-value 
Age Category 
20-29 
30-39 
40-49 
50-59 
60-69 
70-79 
80+ 
 
0.11(0.11-1.00) 
0.52(0.17-1.61) 
1(base) 
2.63(1.03-6.70) 
2.85(1.08-7.50) 
1.59(0.51-5.03) 
1.51(0.35-6.51) 
 
0.05 
0.262 
 
0.042 
0.034 
0.426 
0.577 
Long employment 
Construction & chemic 
Mining 
Manufacturing & Factory 
Engineering 
Drivers 
General worker 
Office & other 
 
2.23(0.66-7.51) 
2.61(0.38-17.96) 
0.55(0.20-1.52) 
0.42(0.11-1.62) 
2.19(0.70-6.86) 
1.79(0.93-3.45) 
1(base) 
 
0.196 
0.329 
0.248 
0.208 
0.178 
0.083 
White meat week 
No 
Low 
High 
 
1(base) 
0.38(0.09-1.61) 
0.18(0.04-0.86) 
 
 
0.190 
0.032 
Fish week 
No 
Low 
High 
 
1(base) 
2.17(1.06-4.45) 
0.30(0.02-3.70) 
 
 
0.034 
0.346 
Fried week 
No 
Low 
High 
 
1(base) 
0.48(0.23-1.00) 
0.59(0.16-2.15) 
 
 
0.050 
0.425 
Vegetable week 
No 
Low 
 
1(base) 
0.33(0.09-1.17) 
 
 
0.085 
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High 0.17(0.05-0.61) 0.007 
 
